175.34
前日終値:
$175.34
開ける:
$174.87
24時間の取引高:
3.77M
Relative Volume:
1.49
時価総額:
$47.86B
収益:
$20.87B
当期純損益:
$1.50B
株価収益率:
33.46
EPS:
5.24
ネットキャッシュフロー:
$2.59B
1週間 パフォーマンス:
+6.17%
1か月 パフォーマンス:
-13.10%
6か月 パフォーマンス:
-24.17%
1年 パフォーマンス:
-26.00%
Becton Dickinson Co Stock (BDX) Company Profile
BDX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
BDX
Becton Dickinson Co
|
175.34 | 47.86B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ISRG
Intuitive Surgical Inc
|
563.95 | 190.13B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
ALC
Alcon Inc
|
93.25 | 48.17B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
RMD
Resmed Inc
|
247.65 | 35.48B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
COO
The Cooper Companies, Inc.
|
81.76 | 16.11B | 3.90B | 392.30M | 288.10M | 1.95 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-05-02 | ダウングレード | Goldman | Buy → Neutral |
2025-05-02 | ダウングレード | Piper Sandler | Overweight → Neutral |
2025-05-02 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2025-05-01 | ダウングレード | BofA Securities | Buy → Neutral |
2025-05-01 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2025-05-01 | ダウングレード | William Blair | Outperform → Mkt Perform |
2024-10-01 | アップグレード | Citigroup | Neutral → Buy |
2024-05-30 | 開始されました | Goldman | Buy |
2023-07-24 | アップグレード | Raymond James | Mkt Perform → Outperform |
2023-05-30 | 再開されました | Morgan Stanley | Overweight |
2023-05-05 | アップグレード | Piper Sandler | Neutral → Overweight |
2023-04-12 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
2023-01-03 | アップグレード | BofA Securities | Neutral → Buy |
2022-12-12 | アップグレード | Citigroup | Sell → Neutral |
2022-07-11 | ダウングレード | Citigroup | Neutral → Sell |
2022-06-24 | アップグレード | Wells Fargo | Equal Weight → Overweight |
2022-03-18 | 再開されました | Raymond James | Mkt Perform |
2022-03-02 | 再開されました | BofA Securities | Neutral |
2021-12-08 | ダウングレード | Piper Sandler | Overweight → Neutral |
2021-08-06 | ダウングレード | JP Morgan | Overweight → Neutral |
2021-05-25 | 開始されました | Barclays | Equal Weight |
2020-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2020-12-15 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2020-07-09 | アップグレード | Barclays | Equal Weight → Overweight |
2020-06-01 | 再開されました | Goldman | Buy |
2020-03-05 | 開始されました | Citigroup | Neutral |
2020-02-07 | ダウングレード | Cowen | Outperform → Market Perform |
2020-02-07 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
2020-02-07 | ダウングレード | Raymond James | Strong Buy → Outperform |
2020-02-06 | ダウングレード | Cowen | Outperform → Market Perform |
2020-01-08 | ダウングレード | Barclays | Overweight → Equal Weight |
2019-05-13 | アップグレード | Barclays | Equal Weight → Overweight |
2018-12-07 | 開始されました | Deutsche Bank | Buy |
2018-10-16 | 開始されました | Barclays | Equal Weight |
2018-06-21 | アップグレード | JP Morgan | Neutral → Overweight |
2018-04-10 | アップグレード | Citigroup | Neutral → Buy |
2018-01-19 | 再開されました | BofA/Merrill | Buy |
2018-01-05 | アップグレード | Citigroup | Sell → Neutral |
2018-01-05 | 開始されました | KeyBanc Capital Mkts | Overweight |
2018-01-03 | 開始されました | Evercore ISI | Outperform |
2017-12-29 | 繰り返されました | Deutsche Bank | Buy |
すべてを表示
Becton Dickinson Co (BDX) 最新ニュース
Becton Dickinson at Bank of America Conference: Navigating Challenges and Opportunities - Investing.com
Becton Dickinson Says Baxter Infringes Infusion-Pump Patents - Bloomberg Law News
Sterile Lancets Market Set to Grow | Key Players: Roche, Becton Dickinson, Medtronic - openPR.com
Becton Dickinson (BDX) Unveils Advanced Cell Analyzer - GuruFocus
BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies - marketscreener.com
First Eagle Investment's Strategic Moves: Spotlight on Becton Dickinson & Co - Yahoo Finance
Becton Dickinson & Co (BDX) Shares Up 3.73% on May 12 - GuruFocus
The Strong Earnings Posted By Becton Dickinson (NYSE:BDX) Are A Good Indication Of The Strength Of The Business - Yahoo
Tissue Diagnostics Market to Reach $12.4 Billion by 2029, Growing at 7.0% CAGR - GlobeNewswire Inc.
Judge declares mistrial in punitive damages phase in Walker v. BD - The Covington News
Becton, Dickinson downgraded at more firms following Q2 results - MSN
Becton Dickinson downgraded to Neutral from Buy at Goldman Sachs - MSN
Jim Cramer on Becton, Dickinson and Company (BDX): “A Shocking Miss for This Once-Reliable Med Tech Giant” - Insider Monkey
Mistrial declared after jury awards $50M in landmark toxic gas case - AJC.com
Becton Dickinson (NYSE:BDX) Sees 18% Price Dip Over Last Week - Yahoo Finance
Becton Dickinson (BDX) Price Target Lowered by Morgan Stanley | BDX Stock News - GuruFocus
Investors Can Still File Late Claims for Becton, Dickinson & Co $85M Settlement Payouts - TradingView
Morgan Stanley Adjusts Price Target on Becton, Dickinson and Company to $196 From $280, Maintains Overweight Rating - marketscreener.com
Covington resident wins $20 million in case against Becton Dickinson - The Covington News
Becton, Dickinson, and Company (BDX): Among the Best Falling Stocks to Buy According to Analysts - Insider Monkey
Piper Sandler Downgrades Becton, Dickinson and (WBAG:BDX) - Nasdaq
Becton, Dickinson and Company (NYSE:BDX) Q2 2025 Earnings Call Transcript - Insider Monkey
William Blair Downgrades Becton, Dickinson and (XTRA:BOX) - Nasdaq
Becton Dickinson Vitals Drop: Analysts 'Have Been Wrong' On This Med Tech Stock For Years - Benzinga
Jefferies cuts Becton Dickinson target to $255, maintains Buy By Investing.com - Investing.com Nigeria
Raymond James cuts Becton Dickinson stock rating to Market Perform By Investing.com - Investing.com Nigeria
Becton, Dickinson Shares Drop After Multiple Analyst Downgrades - marketscreener.com
Becton Dickinson (BDX) Faces Downgrades Amid Growth Concerns - GuruFocus
Goldman Sachs cuts Becton Dickinson stock rating to neutral By Investing.com - Investing.com Nigeria
Becton Dickinson downgraded to Neutral from Overweight at Piper Sandler - TipRanks
Becton Dickinson (BDX) Sees Downgrade and Price Target Cut by Piper Sandler | BDX Stock News - GuruFocus
Becton Dickinson (BDX) Rating Maintained by Stifel, Price Target Lowered | BDX Stock News - GuruFocus
Wall Street analysts downgrade Becton Dickinson & Co. as ’confidence eroded’ - Investing.com
Medical Equipment Makers Stryker, Becton Eye Price Hikes to Offset Tariffs - Bloomberg.com
Becton Dickinson (BDX) Faces Downgrade Amid Growth and Tariff Co - GuruFocus
Jefferies cuts Becton Dickinson target to $255, maintains Buy - Investing.com
Raymond James cuts Becton Dickinson stock rating to Market Perform - Investing.com
Becton Dickinson (BDX) Downgraded Due to Execution Concerns | BD - GuruFocus
Becton Dickinson (BDX) Downgraded Due to Execution Concerns | BDX Stock News - GuruFocus
Becton Dickinson (BDX) Receives Downgrade as Growth Forecasts Lo - GuruFocus
Becton Dickinson (BDX) Receives Downgrade as Growth Forecasts Lowered | BDX Stock News - GuruFocus
Becton Dickinson & Co (BDX) Q2 2025 Earnings Call Highlights: St - GuruFocus
Piper Sandler cuts Becton Dickinson stock rating to neutral By Investing.com - Investing.com Nigeria
Goldman Sachs cuts Becton Dickinson stock rating to neutral - Investing.com
Becton Dickinson & Co (BDX) Q2 2025 Earnings Call Highlights: Strong EPS Growth Amid ... - Yahoo Finance
Piper Sandler cuts Becton Dickinson stock rating to neutral - Investing.com
Becton, Dickinson Reports Q2 2025 Earnings Growth - TipRanks
Becton Dickinson (BDX) Downgraded to Market Perform by William B - GuruFocus
Becton Dickinson: Fiscal Q2 Earnings Snapshot - CT Insider
Becton Dickinson (BDX) Price Target Cut Amid Disappointing FY25 Outlook | BDX Stock News - GuruFocus
Stifel cuts Becton Dickinson target to $224, maintains buy By Investing.com - Investing.com Nigeria
Becton Dickinson Co (BDX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):